Lorrain Daniel S.
Chief Scientific Officer
Lorrain Daniel S. has filed 12 SEC Form 4 filings (27 transaction rows) across 1 company, with disclosures dating back to 2025. 12 of those filings fall inside the rolling window. Most recent filing: Jul 10, 2026.
Companies traded
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.1M
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| CTNM | Chief Scientific Officer | Sale | 1,015 | $16K | Jul 10 | SEC ↗ | |
| CTNM | Chief Scientific Officer | Sale | 25 | $400 | Jul 10 | SEC ↗ | |
| CTNM | Chief Scientific Officer | Sale | 28,826 | $462K | Jul 2 | SEC ↗ | |
| CTNM | Chief Scientific Officer | Sale | 8,353 | $132K | Jul 2 | SEC ↗ | |
| CTNM | Chief Scientific Officer | Sale | 4,170 | $55K | Jun 1 | SEC ↗ | |
| CTNM | Chief Scientific Officer | Sale | 4,170 | $55K | May 1 | SEC ↗ | |
| CTNM | Chief Scientific Officer | Sale | 4,170 | $56K | Apr 6 | SEC ↗ | |
| CTNM | Chief Scientific Officer | Sale | 4,170 | $63K | Mar 2 | SEC ↗ | |
| CTNM | Chief Scientific Officer | Sale | 4,300 | $69K | Feb 26 | SEC ↗ | |
| CTNM | Chief Scientific Officer | Sale | 3,824 | $61K | Feb 26 | SEC ↗ | |
| CTNM | Chief Scientific Officer | Sale | 100 | $2K | Feb 20 | SEC ↗ | |
| CTNM | Chief Scientific Officer | Sale | 400 | $6K | Feb 13 | SEC ↗ | |
| CTNM | Chief Scientific Officer | Sale | 4,170 | $62K | Feb 5 | SEC ↗ | |
| CTNM | Chief Scientific Officer | Sale | 4,170 | $44K | Jan 6 | SEC ↗ | |
| CTNM | Chief Scientific Officer | Sale | 4,170 | $51K | Dec 30 | SEC ↗ |